Show
Sort by
-
- Journal Article
- A2
- open access
Prospective REALITI-A study : 2-year real-world benefits of mepolizumab in severe asthma
-
- Journal Article
- A1
- open access
COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry
-
3TR : a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
-
Health literacy among asthma patients and treatment expectations : results of a Belgian survey
-
- Journal Article
- A1
- open access
COVID-19 and biologics in severe asthma : data from the Belgian Severe Asthma Registry
-
- Journal Article
- A1
- open access
Variability in total serum IgE over 1 year in severe asthmatics
-
Urgent need for pragmatic trial platforms in severe asthma
-
Rhinology future debates 2017 by EUFOREA : novel treatments and surgical solutions in rhinology
-
- Journal Article
- A1
- open access
A Belgian survey on the diagnosis of asthma-COPD overlap syndrome